Profilo
Valerie Salentey is currently the Director of Regulatory Affairs & Quality Assurance at Sensorion SA since 2020.
Prior to this, she worked as the Head of Regulatory Affairs at Neovacs SA from 2018 to 2020, Head of Regulatory Affairs at PPD France SAS in 2018, and Head of Regulatory Affairs at Genethon from 2016 to 2018.
She also worked as the Head of Regulatory Affairs at Cytheris SA from 2008 to 2013.
Posizioni attive di Valerie Salentey
| Società | Posizione | Inizio |
|---|---|---|
| SENSORION | Consigliere Generale | 01/04/2020 |
Precedenti posizioni note di Valerie Salentey
| Società | Posizione | Fine |
|---|---|---|
| NEOVACS | Consigliere Generale | 01/03/2020 |
PPD France SAS
PPD France SAS Miscellaneous Commercial ServicesCommercial Services Provides technical analyzes,tests and inspection services | Consigliere Generale | 01/10/2018 |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Consigliere Generale | 01/01/2018 |
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Consigliere Generale | 01/08/2013 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Neovacs SA
Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
PPD France SAS
PPD France SAS Miscellaneous Commercial ServicesCommercial Services Provides technical analyzes,tests and inspection services | Commercial Services |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
















